Mr. Binns is a former Principal Deputy Assistant Secretary of Defense for International Security Policy, and a Vietnamveteran. He is also former chairman of Parallel Design and past president of ADR Ultrasound, two medical imaging manufacturing companies that he led from startup to merger with General Electric and Squibb, respectively. He is a graduate of StanfordUniversity and HarvardLawSchool.
Carrolee Barlow, MD, PhD
Dr. Barlow serves on the Scientific Advisory Boards and as a consultant in drug development to several companies involved in CNS research. She was the Chief Scientific and Medical Officer of BrainCells Inc., from the founding of the company until 2011. She has previously conducted neuroscience research at the National Institutes of Health, the Salk Institute of Biological Studies, and Merck Research Laboratories. Dr. Barlow is an expert in neuroscience and clinical applications of basic research to neurological and neuropsychiatric diseases. She has authored numerous studies and book chapters in areas ranging from neurogenomics to the implications of basic research for understanding genetic diseases affecting the brain.
Floyd E. Bloom, MD
Dr. Bloom is Professor Emeritus in the Molecular and Integrative Neuroscience Department at The Scripps Research Institute, and was the Founding CEO and Board Chairman of Neurome, Inc. He is a distinguished neuroscientist who pioneered the use of modern molecular biological and database techniques in brain research. Dr. Bloom is a past president of the American Association for the Advancement of Science (AAAS) and a member of the National Academy of Sciences, the Institute of Medicine, the American Philosophical Society, and the RoyalSwedishAcademyof Science. He has authored or coauthored over 700 scientific articles and is the immediate past Editor-in-Chief of Science Magazine.
Beatrice A. Golomb, MD, PhD
Dr. Golomb is Associate Professor of Medicine and of Family and Preventive Medicine at the University of California at San Diego and Research Associate Professor of Psychology at the University of Southern California. Her research focuses on the risks and benefits of medical interventions, especially cholesterol drugs, and on Gulf War veterans’ illnesses. As a RAND scientist, she traveled to the Middle East on a fact-finding mission related to this issue, and has authored several RAND reports on the relation of exposures to illness in Gulf War veterans.
Joel C. Graves, DMin
Rev. Dr. Graves is an Angelican priest and Gulf War veteran. He retired from the U.S. Army in 1997 as a captain, after serving as enlisted for nine years and an armor officer for nine years. During the Gulf War he served as battalion adjutant, responsible for medical and maintenance recovery assets for the 1st Battalion, 67th Armored Regiment of the 1st “Tiger” Brigade Independent Task Force. His unit served on the left flank of the 2nd Marine Division and took the northern part of KuwaitCity. He has Gulf War illness.
Mr. Hardie is a member of the RACGWI, the VA Gulf War Steering Committee, and the Integration Panel of the Peer Reviewed Gulf War Illness Congressionally Directed Medical Research Program (CDMRP). Following his military service, he was elected by his peers as an officer of the National Gulf War Resource Center, where he helped lead efforts resulting in the enactment of the Persian Gulf War Veterans Act of 1998. He medically retired in 2009 due to worsening GWI-related health issues; his last position was Executive Assistant for Legislative, Public and Intergovernmental Affairs, State of Wisconsin Department of Veterans Affairs and included work supporting the National Association of State Directors of Veterans Affairs (NASDVA). He is a graduate of the University of Wisconsin-Madison and a U.S. Army veteran whose seven years of active duty military service included the 1991 Gulf War and Somalia.
Marguerite L. Knox, MN, NP
LTC Knox is a member of the South Carolina Army National Guard’s Medical Command and a Senior Sales Representative for Teva Neuroscience. During the Gulf War she served with the 251st EvacuationHospital at King Khalid Military City, Saudi Arabia. During her tenure as Assistant Professor at the University of South Carolina College of Nursing, she served on the Presidential Advisory Committee on Gulf War Veterans’ Illnesses (1995-1998).
William J. Meggs, MD, PhD
Dr. Meggs is Professor and Chief of the Division of Toxicology, Department of Emergency Medicine at the Brody School of Medicine at EastCarolinaUniversity, where he also serves as Senior Vice Chair for Academic Affairs. His research interests include the role of neurogenic inflammation in chemical sensitivity, and the effects of low-level exposures to organophosphorous compounds. Dr. Meggs is a fellow of the AmericanCollege of Medical Toxicology and the AmericanCollegeof Emergency Medicine, and served on the National Academy of Science’s subcommittee on immunotoxicology.
James P. O’Callaghan, PhD
Dr. O’Callaghan is Distinguished Consultant and Head of the Molecular Neurotoxicology Laboratory in the Toxicology and Molecular Biology Branch of the Health Effects Laboratory Division of the U.S. Centers for Disease Control and Prevention (CDC). Prior to joining CDC, Dr. O’Callaghan founded the molecular and cellular neurotoxicology program in the Neurotoxicology Division, U.S. Environmental Protection Agency in Research Triangle Park, North Carolina. He directs a research program dedicated to the discovery and implementation of biomarkers of neurotoxicity.
Lea Steele, PhD
Dr. Steele is past Scientific Director of the Committee, and Adjunct Associate Professor in the College of Human Ecology at KansasStateUniversity. She is an epidemiologist and human ecologist whose research interests focus on the study of complex medical conditions that are difficult to diagnose and treat. Dr. Steele previously directed the Kansas Persian Gulf War Veterans Health Initiative, a state-sponsored research and service program, and was principal investigator of the Kansas Gulf Veterans Health Study.
Kimberly Sullivan, PhD (Associate Scientific Director)
Dr. Sullivan is a Research Assistant Professor at the Boston University School of Public Health department of Environmental Health. Dr. Sullivan has worked in the field of behavioral neurotoxicology since 1995. She has coordinated field studies in neurotoxicology (i.e., pesticides, methylmercury), neurobehavioral outcomes and the effects of stressors and genetic predisposition to disease on cognitive functioning. She was the Principal Investigator (PI) on a study of cognition and structural MRI in pesticide-exposed Gulf War veterans and most recently is the PI on a multisite consortium study of the pathobiology of Gulf War Illness.
Roberta F. White, PhD (Scientific Director)
Dr. White is Professor and Chair of the Department of Environmental Health at Boston University School of Public Health. She is a neuropsychologist with expertise in environmental and occupational epidemiology. Author of numerous scientific publications, her research interests include evaluation of chronic effects of exposure to neurotoxins, the use of imaging in behavioral toxicology, and gene-environment interactions that mediate the development of neurodegeneration following chronic exposures. Dr. White’s current research projects include evaluation of cognitive function in military personnel who worked as pesticide applicators in the Gulf War, cognitive and neuroimaging correlates of Gulf War service, effects of prenatal pesticide exposures in South African children, and effects of metal exposures in the Framingham Heart Study cohort.
Consultant to the Committee
Jack Melling, PhD
Dr. Melling is former Chief Executive of the U.K. Microbiological Research Authority. He was previously Director of the Salk Institute of Biologicals Development Center, Director of the Karl Landsteiner Institute for Vaccine Development, and a Senior Program Manager at the Battelle Memorial Institute. He is currently a consultant to the United States Government Accountability Office.